Phenylketonuria clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study of JNT-517 in Participants With Phenylketonuria (PKU)
- A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
- Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
- A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria
- Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria
- Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria
- A Study of MZE782 in Adults With PKU
- A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
- Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
- Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
- PKU Protein Requirements
- Long-Term Follow Up Study of Subjects Previously Administered HMI 102
- Early Check: Expanded Screening in Newborns
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Phenylketonuria” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.